Review
Immunosuppressive drugs
Affiliations
- PMID: 1282440
Item in Clipboard
Review
Immunosuppressive drugs
Br J Hosp Med.
1992 Nov.
Abstract
The success rate of clinical transplantation has improved considerably over the last two decades largely due to better immunosuppressive drugs. Allograft rejection remains the major cause of graft loss in renal transplant recipients. This article reviews the mechanisms of action of immunosuppressive drugs and their clinical use.
Similar articles
-
Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.Transplant Proc. 1996 Apr;28(2):998-9. Transplant Proc. 1996. PMID: 8623495 Clinical Trial. No abstract available.
-
[Immunology in clinical practice. VI. Current immunosuppressive drugs].Ned Tijdschr Geneeskd. 1997 Nov 22;141(47):2289-92. Ned Tijdschr Geneeskd. 1997. PMID: 9550813 Dutch.
-
Nursing implications of immunosuppression in transplantation.Nurs Clin North Am. 1991 Jun;26(2):291-314. Nurs Clin North Am. 1991. PMID: 1904575 Review.
-
FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.Transplant Proc. 1996 Dec;28(6):3166-8. Transplant Proc. 1996. PMID: 8962227 Clinical Trial. No abstract available.
-
Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.Drugs. 1996 May;51(5):865-94. doi: 10.2165/00003495-199651050-00010. Drugs. 1996. PMID: 8861551 Review.
Cited by
-
The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB.J Exp Med. 1996 Apr 1;183(4):1829-40. doi: 10.1084/jem.183.4.1829. J Exp Med. 1996. PMID: 8666939 Free PMC article.